The Sabin Vaccine Institute has begun a Phase II trial in the US to evaluate its Marburg vaccine, with the first doses being ...

Currently, there are no approved vaccines for Marburg virus disease.

The USPTO’s recognition of our Marburg vaccine technology further validates our approach ... MARV typically appears in sporadic outbreaks throughout Africa and the virus continues to pose potential ...

Sabin’s vaccine development efforts, including clinical trials, are becoming increasingly critical as Marburg outbreaks grow in frequency, underscoring the urgent need for vaccines to protect ...

Sabin is developing the vaccine amid more frequent outbreaks of the Marburg virus disease, highlighting the need for vaccines to protect high-risk populations. During Rwanda's Marburg outbreak ...